PBYI Dec 2024 2.500 call
OPR - OPR Delayed price. Currency in USD
Add to watchlist
As of 12:05PM EDT. Market open.
| Previous close | 2.3600 |
| Open | 2.3600 |
| Bid | 0.0000 |
| Ask | 0.0000 |
| Strike | 2.50 |
| Expiry date | 2024-12-20 |
| Day's range | 2.3600 - 2.3600 |
| Contract range | N/A |
| Volume | |
| Open interest | N/A |
Business WirePuma Biotechnology Announces Presentation of Findings from a Phase II Study of Alisertib in Endocrine-Resistant Metastatic Breast Cancer (TBCRC 041)
LOS ANGELES, June 02, 2024--Puma Biotechnology announced that findings from the Phase II trial of its drug alisertib (TBCRC 041) were presented at the ASCO 2024 Annual Meeting.
Business WirePuma Biotechnology to Join Russell 3000 Index
LOS ANGELES, May 28, 2024--Puma Biotechnology is on the preliminary list of additions to the Russell 3000 Index.
Simply Wall St.With 49% ownership, Puma Biotechnology, Inc. (NASDAQ:PBYI) has piqued the interest of institutional investors
Key Insights Given the large stake in the stock by institutions, Puma Biotechnology's stock price might be vulnerable...
© 2024 Yahoo. All rights reserved.